Related Links
Nature: Scientific Reports publication
Dizziness Trial on ClinicalTrials.gov
Healthy Volunteer Trial on ClinicalTrials.gov
The CAVA Team
Mr John Phillips
Principal Investigator
Email: j.phillips@uea.ac.uk
Tel: +44 (0)1603 593054
Location:BIO 2.17
Professor Stephen Cox
Co Investigator
Email: sjc@uea.ac.uk
Tel: +44 (0)1603 593054
Location: BIO 2.17
Dr Gregory Howard
Clinical Trials Manager
Email: gregory.Howard@uea.ac.uk
Tel: +44 (0) 07709249306
Location: MED 2.17
Juliet High
Research Lead (NCTU)
Email: j.high@uea.ac.uk
Tel: +44 (0)1603 59 1708
Location: Norwich Clinical Trials Unit
Dr Emmanuel Jammeh
Research Fellow
Email: e.jammeh@uea.ac.uk
Tel: +44 (0)1603 593054
Location: BIO 2.17
Caitlin Pearce
Clinical Trial Assistant
Location: Norwich Clinical Trials Unit
Email: C.Pearce@uea.ac.uk
Dr Jacob Newman
Senior Research Associate
Email: jacob.newman@uea.ac.uk
Tel: +44 (0)1603 593054
Location: BIO 2.17
Contact Us
T: 01603 593054
CAVA Office (BIO 2.17)
School of Computing Sciences
University of East Anglia
Norwich Research Park
Norwich
NR4 7TJ
This project is funded by the Medical Research Council
CAVA is a UK Government funded project to develop a device for monitoring dizziness.
The project has been funded since November 1st 2017. Initial funding was from the Medical Research Council (MRC) and CAVA is currently funded by the National Institute for Health Research (NIHR) until June 2025.
The core CAVA team is based at the University of East Anglia (UEA), and comprises Principal Investigator Mr John Phillips, Co Investigator Professor Stephen Cox, and Research Associate Dr Emmanuel Jammeh. From September 2022, CAVA will be trialled at ten hospital centres around the UK.
The CAVA device was developed in conjunction with a design agency (Wright Design Limited), with supporting computer algorithms being developed by the team at UEA and especially Dr Jacob Newman of UEA.
